About: Evanthia Diamanti-Kandarakis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evanthia Diamanti-Kandarakis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher ORCID ID = 0000-0003-2063-7319

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) researcher ORCID ID = 0000-0003-2063-7319 (en)
rdfs:label	Evanthia Diamanti-Kandarakis (en) Evanthia Diamanti-Kandarakis (es) Evanthia Diamanti-Kandarakis (nl) Evanthia Diamanti-Kandarakis (ast)
skos:prefLabel	Evanthia Diamanti-Kandarakis (en) Evanthia Diamanti-Kandarakis (es) Evanthia Diamanti-Kandarakis (nl) Evanthia Diamanti-Kandarakis (ast)
name	Evanthia Diamanti-Kandarakis (en) Evanthia Diamanti-Kandarakis (es) Evanthia Diamanti-Kandarakis (nl) Evanthia Diamanti-Kandarakis (ast)
instance of	wds:Q60821404-DDC37C08-5BCD-462E-9EDF-59F56DD4C456
instance of	Homo sapiens
occupation	wds:Q60821404-60AF02B0-FDB3-4728-BEF6-7232F0977F74
NUKAT ID	wds:Q60821404-C83A6149-7C30-47A6-9712-3EEA68E8C3E0
ISNI	wds:Q60821404-F04CEBA2-0204-4855-BC0A-393355C697E1
VIAF ID	wds:Q60821404-C85549E9-085D-43C1-936B-5369D4464F1C
Library of Congress authority ID	wds:Q60821404-B39D46A0-5F8E-4556-8D8E-C0F7F0388775
WorldCat Identities ID (superseded)	wds:Q60821404-1E8CC514-15BD-466F-8F1F-D901A5FAC7E2
National Library of Israel J9U ID	wds:Q60821404-23D1D18E-4114-41E6-8032-58036882CB13
VIAF ID	http://viaf.org/viaf/75776631
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2007184039
occupation	researcher
NUKAT ID	n2013176699
ISNI	0000000036989851
VIAF ID	75776631
Library of Congress authority ID	n2007184039
WorldCat Identities ID (superseded)	lccn-n2007184039
National Library of Israel J9U ID	987007371480205171
ORCID iD	wds:Q60821404-DCE8EEE5-34B1-4EFC-A31C-E8FF80AF9F90
ORCID iD	https://orcid.org/0000-0003-2063-7319
ORCID iD	0000-0003-2063-7319
is owl:sameAs of	Evanthia Diamanti-Kandarakis
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60821404
is author of	Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Accumulation of dietary glycotoxins in the reproductive system of normal female rats. Role of obesity and adiposity in polycystic ovary syndrome Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Molecular mechanisms of insulin resistance in polycystic ovary syndrome Advanced glycation end-products and insulin signaling in granulosa cells Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Current aspects of antiandrogen therapy in women. Androgens and therapeutic aspects of antiandrogens in women Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS) Metformin administration improves endothelial function in women with polycystic ovary syndrome Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. Endocrine-disrupting chemicals: an Endocrine Society scientific statement The impact of endocrine disruptors on endocrine targets The polycystic ovary syndrome: a position statement from the European Society of Endocrinology European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents? Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism Metformin in polycystic ovary syndrome MECHANISMS IN ENDOCRINOLOGY: Nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. Serum and seminal plasma ghrelin levels in men with normospermia and dyspermia Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome New perspectives in polycystic ovary syndrome Industrial endocrine disruptors and polycystic ovary syndrome Polycystic ovary syndrome: the influence of environmental and genetic factors Pathophysiology and types of dyslipidemia in PCOS. Hormone replacement therapy and risk of malignancy Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome The role of genes and environment in the etiology of PCOS. The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software